Restart Life Sciences Corp.
HEAL
Peringkat dalam Saham
#35828
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Harga Saham
$0.05137558
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$3.21M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
78.84%
Negara
CA
Perdagangan Restart Life Sciences Corp. (HEAL)
Kategori
Healthcare
Riwayat hasil dividen untuk Restart Life Sciences Corp. (HEAL)
Hasil dividen (TTM) dari Restart Life Sciences Corp. (simbol saham: HEAL) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Restart Life Sciences Corp. (HEAL) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
| Perusahaan | Hasil Dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
